GUARDANT HEALTH, INC. Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
GUARDANT HEALTH, INC. (GH) reported Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents of -$605.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Change in Cash
us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-07-30
- GUARDANT HEALTH, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2026-03-31 was -$194.00K, a 125.10% decline year-over-year.
- GUARDANT HEALTH, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2025-03-31 was $773.00K.
- GUARDANT HEALTH, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2024-03-31 was -$1.14M.
- GUARDANT HEALTH, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2023-03-31 was -$163.00K.
| Period end | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9 month |
|---|---|---|---|
| 2026-06-30 | -$605.00K 10-Q · filed 2026-07-30 | ||
| 2026-03-31 | -$194.00K 10-Q · filed 2026-05-07 | ||
| 2025-09-30 | $1.18M 10-Q · filed 2025-10-29 | ||
| 2025-06-30 | $1.71M 10-Q · filed 2026-07-30 | ||
| 2025-03-31 | $773.00K 10-Q · filed 2026-05-07 | ||
| 2024-09-30 | -$75.00K 10-Q · filed 2025-10-29 | ||
| 2024-06-30 | -$1.98M 10-Q · filed 2025-07-30 | ||
| 2024-03-31 | -$1.14M 10-Q · filed 2025-04-30 | ||
| 2023-09-30 | -$1.94M 10-Q · filed 2024-11-06 | ||
| 2023-06-30 | -$1.42M 10-Q · filed 2024-08-07 | ||
| 2023-03-31 | -$163.00K 10-Q · filed 2024-05-09 | ||
| 2022-09-30 | -$2.74M 10-Q · filed 2023-11-06 | ||
| 2022-06-30 | -$2.21M 10-Q · filed 2023-08-03 | ||
| 2022-03-31 | -$792.00K 10-Q · filed 2023-05-09 | ||
| 2021-09-30 | -$1.19M 10-Q · filed 2022-11-03 | ||
| 2021-06-30 | -$1.08M 10-Q · filed 2022-08-04 | ||
| 2021-03-31 | -$1.09M 10-Q · filed 2022-05-05 | ||
| 2020-09-30 | $239.00K 10-Q · filed 2021-11-04 | ||
| 2020-06-30 | $49.00K 10-Q · filed 2021-08-05 | ||
| 2020-03-31 | $23.00K 10-Q · filed 2021-05-06 | ||
| 2019-09-30 | $137.00K 10-Q · filed 2020-11-05 | ||
| 2019-06-30 | $90.00K 10-Q · filed 2020-08-06 | ||
| 2019-03-31 | -$69.00K 10-Q · filed 2020-05-07 | ||
| 2018-09-30 | -$27.00K 10-Q · filed 2019-11-07 | ||
| 2018-06-30 | $0.00 10-Q · filed 2019-08-07 | ||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-10 | ||
| 2017-09-30 | $0.00 10-Q · filed 2018-11-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |